Intraperitoneal immunotherapy of epithelial ovarian carcinoma with Corynebacterium parvum
Authors:
- Jonathan S. BerekJBJonathan S. Berek
- Robert C. KnappRKRobert C. Knapp
- Neville F. HackerNHNeville F. Hacker
- Alan LichtensteinALAlan Lichtenstein
- Tyler JungTJTyler Jung
- Celsa SpinaCSCelsa Spina
- R. ObristROR. Obrist
- C.THomas GriffithsCGC.THomas Griffiths
- Ross S. BerkowitzRBRoss S. Berkowitz
- Leroy ParkerLPLeroy Parker
- Jacob ZighelboimJZJacob Zighelboim
- Robert C. BastRobert C. Bast
- 1 August 1985
- journal article
- research article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 152 (8) , 1003-1010
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Intracavitary Corynebacterium parvum for treatment of malignant effusionsGynecologic Oncology, 1983
- Intraperitoneal administration of corynebacterium parvum in patients with ascitic ovarian tumors resistant to chemotherapy: Effects on cytotoxicity of tumor‐associated macrophages and NK cellsInternational Journal of Cancer, 1981
- Immunotherapy of a Murine Ovarian Carcinoma with Corynebacterium Parvum and Specific HeteroantiserumThe Journal of Immunology, 1979
- Treatment of malignant ascitic and pleural effusion with Corynebacterium parvum.BMJ, 1978
- Corynebacterium parvum as an immunotherapeutic agent in an ovarian cancer modelAmerican Journal of Obstetrics and Gynecology, 1977
- Regression Models and Life-TablesJournal of the Royal Statistical Society Series B: Statistical Methodology, 1972
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958